Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. - Wikidata - awgldk - TriplyDB

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

http://www.wikidata.org/entity/Q37125562

about

Renal Cancer Stem Cells: Characterization and Targeted Therapies Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells Experimental procedures to identify and validate specific mRNA targets of miRNAs Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA Multimodality molecular imaging of CD105 (Endoglin) expression.Intravascular papillary endothelial hyperplasia: histomorphological and immunohistochemical features.A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models ΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.Radiation rescue: mesenchymal stromal cells protect from lethal irradiation.Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood.Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials.Stem cell pathways contribute to clinical chemoresistance in ovarian cancer Theranostic unimolecular micelles based on brush-shaped amphiphilic block copolymers for tumor-targeted drug delivery and positron emission tomography imaging Study of microvessel density and the expression of vascular endothelial growth factors in adrenal gland pheochromocytomas.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.Phenotypic and functional changes in blood monocytes following adherence to endothelium.BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling Endoglin requirement for BMP9 signaling in endothelial cells reveals new mechanism of action for selective anti-endoglin antibodies.An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst Multiple delivery of siRNA against endoglin into murine mammary adenocarcinoma prevents angiogenesis and delays tumor growth Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105 Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status Angiogenesis and lymphangiogenesis in the spectrum of leprosy and its reactional forms.Positron emission tomography imaging of CD105 expression during tumor angiogenesis.Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival Cross-talk between endothelial and tumor cells via basic fibroblast growth factor and vascular endothelial growth factor signaling promotes lung cancer growth and angiogenesis.Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105 Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting.In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis Gene Electrotransfer of Plasmid with Tissue Specific Promoter Encoding shRNA against Endoglin Exerts Antitumor Efficacy against Murine TS/A Tumors by Vascular Targeted Effects.Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105.Endoglin (CD105) expression differentiates between aseptic loosening and periprosthetic joint infection after total joint arthroplasty Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.Tumor neoangiogenesis detection by confocal laser endomicroscopy and anti-CD105 antibody: Pilot study.

P2860

Q26746970-6A073898-CECC-4BE9-BE8C-F795D16375A4 Q27315862-A738266A-A36D-4A5F-8779-28008964B9E5 Q28078154-E67275A9-3848-4315-BDE1-00BD79E4AB90 Q28087216-58A245D2-52CE-4AC8-AE23-E66DE84F811F Q28741667-660EBDB0-139C-472D-9BC7-72AAC4BDAEEF Q30476445-2EB2B121-12EA-48D9-B6F7-F264A4ECED49 Q33590331-7744A142-5DF9-4AC4-9DF9-EFC099FB225B Q33634727-DC2B99B8-AA80-47A4-AF98-7776AEA5A5F8 Q33640207-7D535673-417C-44EB-B1E0-73447B8A8D46 Q33688451-F6B45BFA-E7B2-49C3-8973-17AF86212264 Q33796581-22877E26-1CA5-41AB-B9B6-F21DBB572F1B Q33916338-A61C2650-B288-444A-860F-C0E70F0CFF8B Q34019838-4C3E6FB3-14E8-4842-A411-CBF18B51EE36 Q34092005-326A3D63-8DF4-4D7D-B3FE-0963381454EA Q34178035-3E323B94-B9F4-43B2-A017-C077E5C12955 Q34206444-4F352B20-60B0-45D6-B351-17A408195DD1 Q34216877-264343AC-75CE-4F5C-B9E3-7D25124CC28A Q34277715-8243D14B-9C98-439B-96BC-08E62EDBEEFC Q34454218-560C24CE-F8F0-4BEB-929F-4B9250CE3965 Q34458617-16FCBE01-D916-46CA-81F5-955D7ACE818E Q34464099-79923261-6205-4584-BEA7-A5ED0F61BAEA Q34500187-BFD5505B-5600-4825-8C24-0AECA1A966E7 Q34540047-2F0CE1D2-84B0-42D2-8A00-1C3EF60A259B Q34587927-5B54EFA8-5A47-46E0-8305-E7F533D3DE79 Q34672107-12EF5310-989D-4CAC-AF45-EFE183521ABA Q34759659-ACFB2954-8EC7-4634-B721-DB40CFD78F3C Q34978084-F4D81D1C-4611-4C16-A030-8D58E0FC62DA Q34990214-22AEB34D-462C-43B4-944F-8555C30911A5 Q35017120-2D5FFB6B-EDCF-49DB-A765-4263DA367C3D Q35022205-934D25F9-CA65-4B50-8C03-9A0B06AB75E7 Q35042233-45153453-D1F1-4C33-B1CA-DFDCC098396D Q35071225-1E4E5568-64A8-4CA4-A263-811D30103C99 Q35079462-E6B691BD-36C1-43E3-A210-87E5E1CB2C48 Q35291271-EF8F4A7E-7BDA-4E95-8901-5E0A66F375DD Q35536671-2DC197DA-03F1-42F5-BF63-6B9FB04B38C5 Q35587248-07961CC5-5532-447B-A368-1B7295144BB8 Q35661573-376289A0-1EBD-49E0-834B-37B7118815E7 Q35664735-E25ADB62-E20A-4DCB-B4A5-9FAF49F62702 Q35809541-C7D6CF3A-984D-4BBF-B02A-9AFB5B5E3630 Q35851032-953DC5AE-3AA9-4920-A62E-B18FA67E5610

P2860

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

http://www.wikidata.org/entity/Q37125562

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

@en

Endoglin

@nl

type

label

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

@en

Endoglin

@nl

prefLabel

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

@en

Endoglin

@nl

P1433

Q37125562-3E966F35-7724-48B8-AD67-9AF2D3B77B74

P1476

Q37125562-5E16631D-03C7-47EA-B91F-2C02B79A33CD

P2093

Q37125562-14359D09-4B28-45AA-97E4-B55425C542F9

Q37125562-34BF2E37-4C66-47FC-AF32-C2666A9EEE6D

Q37125562-36E9B27E-1723-4506-B8BD-5DAA937F240D

Q37125562-468D2228-2E80-4DBD-9D6E-5072FD4AD620

Q37125562-568FB36A-38DA-486C-8949-B92CCDE89F64

Q37125562-5CC6E992-A169-4D0E-8695-641A59060266

Q37125562-F496BFE9-8AC3-4DC6-8F0D-15E66279ED06

P304

Q37125562-E0777B44-C17F-433B-AC16-EE0DFF45E250

P31

Q37125562-08681114-536D-4457-A3B2-B1400F6DD1A6

P356

Q37125562-4B6ACFA3-C125-4D72-BB79-D94D098BDB65

P407

Q37125562-3AF12DA8-27AA-4115-90EC-A7B7335F6237

P433

Q37125562-55C96551-78A2-4D99-8EDF-79A954C64F6B

P478

Q37125562-9BD65B8B-45AC-45ED-BF3A-56FCA2EEAABD

P577

Q37125562-5D5BD255-4C9E-47A9-8C6B-0BDF0A9A4A12

P698

Q37125562-14CB8AF4-8AAA-4CA2-BB36-78714B88406C

P356

1078-0432.CCR-07-4478

P1433

Clinical Cancer Research

P1476

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.

@en

P2093

Fan Fan

http://www.w3.org/2001/XMLSchema#string

Lee M Ellis

http://www.w3.org/2001/XMLSchema#string

Ling Xia

http://www.w3.org/2001/XMLSchema#string

Michael J Gray

http://www.w3.org/2001/XMLSchema#string

Nikolaos A Dallas

http://www.w3.org/2001/XMLSchema#string

Shaija Samuel

http://www.w3.org/2001/XMLSchema#string

Sherry J Lim

http://www.w3.org/2001/XMLSchema#string

P304

1931-1937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-4478

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18381930

http://www.w3.org/2001/XMLSchema#string